Myoclonus in parkinsonian disorders.
Shafiq
Mohamed
M
Department of Medicine (Neurology), Toronto Western Hospital, Toronto, Ontario, Canada.
Lang
Anthony E
AE
D000978:Antiparkinson Agents / Q000009:adverse effects; D001479:Basal Ganglia; D002540:Cerebral Cortex; D006801:Humans; D020961:Lewy Body Disease / Q000150:complications; D019578:Multiple System Atrophy / Q000150:complications; D009207:Myoclonus / Q000139:chemically induced / Q000209:etiology*; D009410:Nerve Degeneration / Q000150:complications; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D020734:Parkinsonian Disorders / Q000150:complications*
D000978:Antiparkinson Agents